Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Erratum for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21".

Ramakrishnan A, Schumack NM, Gariepy CL, Eggleston H, Nunez G, Espinoza N, Nieto M, Castillo R, Rojas J, McCoy AJ, Beck Z, Matyas GR, Alving CR, Guerry P, Poly F, Laird RM.

mSphere. 2019 Jun 26;4(3). pii: e00440-19. doi: 10.1128/mSphere.00440-19. No abstract available.

2.

Correction for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21".

Ramakrishnan A, Schumack NM, Gariepy CL, Eggleston H, Nunez G, Espinoza N, Nieto M, Castillo R, Rojas J, McCoy AJ, Beck Z, Matyas GR, Alving CR, Guerry P, Poly F, Laird RM.

mSphere. 2019 May 22;4(3). pii: e00351-19. doi: 10.1128/mSphere.00351-19. No abstract available.

3.

Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21.

Ramakrishnan A, Schumack NM, Gariepy CL, Eggleston H, Nunez G, Espinoza N, Nieto M, Castillo R, Rojas J, McCoy AJ, Beck Z, Matyas GR, Alving CR, Guerry P, Poly F, Laird RM.

mSphere. 2019 May 1;4(3). pii: e00101-19. doi: 10.1128/mSphere.00101-19. Erratum in: mSphere. 2019 May 22;4(3):. mSphere. 2019 Jun 26;4(3):.

4.

Campylobacter jejuni capsule types in a Peruvian birth cohort and associations with diarrhoeal disease severity.

Neitenbach B, Poly F, Kuroiwa J, Burga R, Olortegui MP, Guerry P, Kosek M, Porter CK.

Epidemiol Infect. 2019 Jan;147:e149. doi: 10.1017/S0950268818002960.

PMID:
30868983
5.

A multi-substrate screening approach for the identification of a broadly applicable Diels-Alder catalyst.

Kim H, Gerosa G, Aronow J, Kasaplar P, Ouyang J, Lingnau JB, Guerry P, Farès C, List B.

Nat Commun. 2019 Feb 15;10(1):770. doi: 10.1038/s41467-019-08374-z.

6.

Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella.

Laird RM, Ma Z, Dorabawila N, Pequegnat B, Omari E, Liu Y, Maue AC, Poole ST, Maciel M, Satish K, Gariepy CL, Schumack NM, McVeigh AL, Poly F, Ewing CP, Prouty MG, Monteiro MA, Savarino SJ, Guerry P.

Vaccine. 2018 Oct 29;36(45):6695-6702. doi: 10.1016/j.vaccine.2018.09.052. Epub 2018 Sep 27.

7.

A novel mouse model of Campylobacter jejuni enteropathy and diarrhea.

Giallourou N, Medlock GL, Bolick DT, Medeiros PH, Ledwaba SE, Kolling GL, Tung K, Guerry P, Swann JR, Guerrant RL.

PLoS Pathog. 2018 May 23;14(3):e1007083. doi: 10.1371/journal.ppat.1007083. eCollection 2018 Mar.

8.

Campylobacter jejuni transcriptional and genetic adaptation during human infection.

Crofts AA, Poly FM, Ewing CP, Kuroiwa JM, Rimmer JE, Harro C, Sack D, Talaat KR, Porter CK, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Maue AC, Jaep K, Alcala A, Tribble DR, Riddle MS, Ramakrishnan A, McCoy AJ, Davies BW, Guerry P, Trent MS.

Nat Microbiol. 2018 Apr;3(4):494-502. doi: 10.1038/s41564-018-0133-7. Epub 2018 Mar 27.

9.

Capsular genotype and lipooligosaccharide locus class distribution in Campylobacter jejuni from young children with diarrhea and asymptomatic carriers in Bangladesh.

Islam Z, Sarker SK, Jahan I, Farzana KS, Ahmed D, Faruque ASG, Guerry P, Poly F, Heikema AP, Endtz HP.

Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):723-728. doi: 10.1007/s10096-017-3165-7. Epub 2017 Dec 21.

PMID:
29270862
10.

Epidemiology of Campylobacter Infections among Children in Egypt.

Sainato R, ElGendy A, Poly F, Kuroiwa J, Guerry P, Riddle MS, Porter CK.

Am J Trop Med Hyg. 2018 Feb;98(2):581-585. doi: 10.4269/ajtmh.17-0469. Epub 2017 Dec 14.

11.

Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.

Rimmer JE, Harro C, Sack DA, Talaat KR, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Poly F, Maue AC, Jaep K, Alcala A, Mochalova Y, Gariepy CL, Chakraborty S, Guerry P, Tribble DR, Porter CK, Riddle MS.

Clin Infect Dis. 2018 Apr 17;66(9):1435-1441. doi: 10.1093/cid/cix1014.

PMID:
29145631
12.

Strong-coupling induced damping of spin-echo modulations in magic-angle-spinning NMR: Implications for J coupling measurements in disordered solids.

Guerry P, Brown SP, Smith ME.

J Magn Reson. 2017 Oct;283:22-32. doi: 10.1016/j.jmr.2017.08.006. Epub 2017 Aug 19.

PMID:
28843058
13.

Phase-Variable Changes in the Position of O-Methyl Phosphoramidate Modifications on the Polysaccharide Capsule of Campylobacter jejuni Modulate Serum Resistance.

Pequegnat B, Laird RM, Ewing CP, Hill CL, Omari E, Poly F, Monteiro MA, Guerry P.

J Bacteriol. 2017 Jun 27;199(14). pii: e00027-17. doi: 10.1128/JB.00027-17. Print 2017 Jul 15.

14.

Status of vaccine research and development for Campylobacter jejuni.

Riddle MS, Guerry P.

Vaccine. 2016 Jun 3;34(26):2903-2906. doi: 10.1016/j.vaccine.2016.02.080. Epub 2016 Mar 11. Review.

15.

Correction: Updated Campylobacter jejuni Capsule PCR Multiplex Typing System and Its Application to Clinical Isolates from South and Southeast Asia.

Poly F, Serichantalergs O, Kuroiwa J, Pootong P, Mason C, Guerry P, Parker CT.

PLoS One. 2016 Mar 7;11(3):e0151410. doi: 10.1371/journal.pone.0151410. eCollection 2016. No abstract available.

16.

Updated Campylobacter jejuni Capsule PCR Multiplex Typing System and Its Application to Clinical Isolates from South and Southeast Asia.

Poly F, Serichantalergs O, Kuroiwa J, Pootong P, Mason C, Guerry P, Parker CT.

PLoS One. 2015 Dec 2;10(12):e0144349. doi: 10.1371/journal.pone.0144349. eCollection 2015. Erratum in: PLoS One. 2016;11(3):e0151410.

17.

Synthesis and immunodetection of 6-O-methyl-phosphoramidyl-α-D-galactose: a Campylobacter jejuni antigenic determinant.

Jiao Y, Ma Z, Ewing CP, Guerry P, Monteiro MA.

Carbohydr Res. 2015 Dec 11;418:9-12. doi: 10.1016/j.carres.2015.09.012. Epub 2015 Oct 3.

PMID:
26513759
18.

Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome.

Heikema AP, Islam Z, Horst-Kreft D, Huizinga R, Jacobs BC, Wagenaar JA, Poly F, Guerry P, van Belkum A, Parker CT, Endtz HP.

Clin Microbiol Infect. 2015 Sep;21(9):852.e1-9. doi: 10.1016/j.cmi.2015.05.031. Epub 2015 Jun 9.

19.

CASD-NMR 2: robust and accurate unsupervised analysis of raw NOESY spectra and protein structure determination with UNIO.

Guerry P, Duong VD, Herrmann T.

J Biomol NMR. 2015 Aug;62(4):473-80. doi: 10.1007/s10858-015-9934-7. Epub 2015 Apr 28.

PMID:
25917899
20.

Distribution of Campylobacter jejuni capsular types, 2007-2012, Philadelphia, PA.

Garrigan C, Ettela A, Poly F, Guerry P, Nachamkin I.

Diagn Microbiol Infect Dis. 2014 Nov;80(3):204-6. doi: 10.1016/j.diagmicrobio.2014.08.002. Epub 2014 Aug 13.

PMID:
25192792
21.

Rapid proton-detected NMR assignment for proteins with fast magic angle spinning.

Barbet-Massin E, Pell AJ, Retel JS, Andreas LB, Jaudzems K, Franks WT, Nieuwkoop AJ, Hiller M, Higman V, Guerry P, Bertarello A, Knight MJ, Felletti M, Le Marchand T, Kotelovica S, Akopjana I, Tars K, Stoppini M, Bellotti V, Bolognesi M, Ricagno S, Chou JJ, Griffin RG, Oschkinat H, Lesage A, Emsley L, Herrmann T, Pintacuda G.

J Am Chem Soc. 2014 Sep 3;136(35):12489-97. doi: 10.1021/ja507382j. Epub 2014 Aug 18.

22.

A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Maue AC, Poly F, Guerry P.

Hum Vaccin Immunother. 2014;10(6):1499-504. doi: 10.4161/hv.27985. Epub 2014 Mar 14. Review.

23.

High frequency, spontaneous motA mutations in Campylobacter jejuni strain 81-176.

Mohawk KL, Poly F, Sahl JW, Rasko DA, Guerry P.

PLoS One. 2014 Feb 18;9(2):e88043. doi: 10.1371/journal.pone.0088043. eCollection 2014.

24.

Genome Sequence of Salmonella enterica Serovar Typhi Oral Vaccine Strain Ty21a.

Xu D, Cisar JO, Poly F, Yang J, Albanese J, Dharmasena M, Wai T, Guerry P, Kopecko DJ.

Genome Announc. 2013 Aug 22;1(4). pii: e00650-13. doi: 10.1128/genomeA.00650-13.

25.

An isogenic cell panel identifies compounds that inhibit proliferation of mTOR-pathway addicted cells by different mechanisms.

Wyder Peters L, Molle KD, Thiemeyer A, Knopf A, Goxe M, Guerry P, Brodbeck D, Colombi M, Hall MN, Moroni C, Regenass U.

J Biomol Screen. 2014 Jan;19(1):131-44. doi: 10.1177/1087057113497798. Epub 2013 Aug 16.

PMID:
23954931
26.

Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model.

Kirkpatrick BD, Lyon CE, Porter CK, Maue AC, Guerry P, Pierce KK, Carmolli MP, Riddle MS, Larsson CJ, Hawk D, Dill EA, Fingar A, Poly F, Fimlaid KA, Hoq F, Tribble DR.

Clin Infect Dis. 2013 Oct;57(8):1106-13. doi: 10.1093/cid/cit454. Epub 2013 Jul 9.

27.

Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review.

Pike BL, Guerry P, Poly F.

PLoS One. 2013 Jun 27;8(6):e67375. doi: 10.1371/journal.pone.0067375. Print 2013. Review.

28.

Mapping protein conformational energy landscapes using NMR and molecular simulation.

Guerry P, Mollica L, Blackledge M.

Chemphyschem. 2013 Sep 16;14(13):3046-58. doi: 10.1002/cphc.201300377. Epub 2013 May 23.

PMID:
23703956
29.

Mapping the population of protein conformational energy sub-states from NMR dipolar couplings.

Guerry P, Salmon L, Mollica L, Ortega Roldan JL, Markwick P, van Nuland NA, McCammon JA, Blackledge M.

Angew Chem Int Ed Engl. 2013 Mar 11;52(11):3181-5. doi: 10.1002/anie.201209669. Epub 2013 Feb 1. No abstract available.

30.

The design of a capsule polysaccharide conjugate vaccine against Campylobacter jejuni serotype HS15.

Bertolo L, Ewing CP, Maue A, Poly F, Guerry P, Monteiro MA.

Carbohydr Res. 2013 Jan 25;366:45-9. doi: 10.1016/j.carres.2012.11.017. Epub 2012 Dec 2.

PMID:
23261782
31.

The polysaccharide capsule of Campylobacter jejuni modulates the host immune response.

Maue AC, Mohawk KL, Giles DK, Poly F, Ewing CP, Jiao Y, Lee G, Ma Z, Monteiro MA, Hill CL, Ferderber JS, Porter CK, Trent MS, Guerry P.

Infect Immun. 2013 Mar;81(3):665-72. doi: 10.1128/IAI.01008-12. Epub 2012 Dec 17.

32.

Campylobacter polysaccharide capsules: virulence and vaccines.

Guerry P, Poly F, Riddle M, Maue AC, Chen YH, Monteiro MA.

Front Cell Infect Microbiol. 2012 Feb 15;2:7. doi: 10.3389/fcimb.2012.00007. eCollection 2012. Review.

33.

Blind testing of routine, fully automated determination of protein structures from NMR data.

Rosato A, Aramini JM, Arrowsmith C, Bagaria A, Baker D, Cavalli A, Doreleijers JF, Eletsky A, Giachetti A, Guerry P, Gutmanas A, Güntert P, He Y, Herrmann T, Huang YJ, Jaravine V, Jonker HR, Kennedy MA, Lange OF, Liu G, Malliavin TE, Mani R, Mao B, Montelione GT, Nilges M, Rossi P, van der Schot G, Schwalbe H, Szyperski TA, Vendruscolo M, Vernon R, Vranken WF, Vries Sd, Vuister GW, Wu B, Yang Y, Bonvin AM.

Structure. 2012 Feb 8;20(2):227-36. doi: 10.1016/j.str.2012.01.002.

34.

Crystal structure of JlpA, a surface-exposed lipoprotein adhesin of Campylobacter jejuni.

Kawai F, Paek S, Choi KJ, Prouty M, Kanipes MI, Guerry P, Yeo HJ.

J Struct Biol. 2012 Feb;177(2):583-8. doi: 10.1016/j.jsb.2012.01.001. Epub 2012 Jan 8.

35.

Comprehensive automation for NMR structure determination of proteins.

Guerry P, Herrmann T.

Methods Mol Biol. 2012;831:429-51. doi: 10.1007/978-1-61779-480-3_22.

PMID:
22167686
36.

Fast resonance assignment and fold determination of human superoxide dismutase by high-resolution proton-detected solid-state MAS NMR spectroscopy.

Knight MJ, Webber AL, Pell AJ, Guerry P, Barbet-Massin E, Bertini I, Felli IC, Gonnelli L, Pierattelli R, Emsley L, Lesage A, Herrmann T, Pintacuda G.

Angew Chem Int Ed Engl. 2011 Dec 2;50(49):11697-701. doi: 10.1002/anie.201106340. Epub 2011 Oct 13. No abstract available.

PMID:
21998020
37.

N-linked glycosylation in Archaea: two paths to the same glycan.

Guerry P.

Mol Microbiol. 2011 Sep;81(5):1133-5. doi: 10.1111/j.1365-2958.2011.07782.x. Epub 2011 Aug 16.

38.

Distribution of flagella secreted protein and integral membrane protein among Campylobacter jejuni isolated from Thailand.

Pootong P, Serichantalergs O, Bodhidatta L, Poly F, Guerry P, Mason CJ.

Gut Pathog. 2011 Jul 12;3:11. doi: 10.1186/1757-4749-3-11.

39.

Discrimination of major capsular types of Campylobacter jejuni by multiplex PCR.

Poly F, Serichatalergs O, Schulman M, Ju J, Cates CN, Kanipes M, Mason C, Guerry P.

J Clin Microbiol. 2011 May;49(5):1750-7. doi: 10.1128/JCM.02348-10. Epub 2011 Mar 16.

40.

Advances in automated NMR protein structure determination.

Guerry P, Herrmann T.

Q Rev Biophys. 2011 Aug;44(3):257-309. doi: 10.1017/S0033583510000326. Epub 2011 Mar 17. Review.

PMID:
21411039
41.

PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003.

Serichantalergs O, Pootong P, Dalsgaard A, Bodhidatta L, Guerry P, Tribble DR, Anuras S, Mason CJ.

Gut Pathog. 2010 Nov 10;2(1):15. doi: 10.1186/1757-4749-2-15.

42.

Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infection.

Lindow JC, Poly F, Tribble DR, Guerry P, Carmolli MP, Baqar S, Porter CK, Pierce KK, Darsley MJ, Sadigh KS, Dill EA; Campylobacter Study Team, Kirkpatrick BD.

J Clin Microbiol. 2010 Aug;48(8):3012-5. doi: 10.1128/JCM.00768-10. Epub 2010 Jun 16.

43.

Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism.

Baqar S, Tribble DR, Carmolli M, Sadigh K, Poly F, Porter C, Larsson CJ, Pierce KK, Guerry P; Campylobacter Study Team, Darsley M, Kirkpatrick B.

Clin Vaccine Immunol. 2010 Jan;17(1):80-6. doi: 10.1128/CVI.00252-09. Epub 2009 Nov 18.

44.

Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.

Tribble DR, Baqar S, Carmolli MP, Porter C, Pierce KK, Sadigh K, Guerry P, Larsson CJ, Rockabrand D, Ventone CH, Poly F, Lyon CE, Dakdouk S, Fingar A, Gilliland T, Daunais P, Jones E, Rymarchyk S, Huston C, Darsley M, Kirkpatrick BD.

Clin Infect Dis. 2009 Nov 15;49(10):1512-9. doi: 10.1086/644622.

PMID:
19842970
45.

Outer membrane vesicle-mediated release of cytolethal distending toxin (CDT) from Campylobacter jejuni.

Lindmark B, Rompikuntal PK, Vaitkevicius K, Song T, Mizunoe Y, Uhlin BE, Guerry P, Wai SN.

BMC Microbiol. 2009 Oct 16;9:220. doi: 10.1186/1471-2180-9-220.

46.

Functional characterization of flagellin glycosylation in Campylobacter jejuni 81-176.

Ewing CP, Andreishcheva E, Guerry P.

J Bacteriol. 2009 Nov;191(22):7086-93. doi: 10.1128/JB.00378-09. Epub 2009 Sep 11.

47.

CASD-NMR: critical assessment of automated structure determination by NMR.

Rosato A, Bagaria A, Baker D, Bardiaux B, Cavalli A, Doreleijers JF, Giachetti A, Guerry P, Güntert P, Herrmann T, Huang YJ, Jonker HR, Mao B, Malliavin TE, Montelione GT, Nilges M, Raman S, van der Schot G, Vranken WF, Vuister GW, Bonvin AM.

Nat Methods. 2009 Sep;6(9):625-6. doi: 10.1038/nmeth0909-625. No abstract available.

48.

Immune response to and histopathology of Campylobacter jejuni infection in ferrets (Mustela putorius furo).

Nemelka KW, Brown AW, Wallace SM, Jones E, Asher LV, Pattarini D, Applebee L, Gilliland TC Jr, Guerry P, Baqar S.

Comp Med. 2009 Aug;59(4):363-71.

49.
50.

Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni.

Monteiro MA, Baqar S, Hall ER, Chen YH, Porter CK, Bentzel DE, Applebee L, Guerry P.

Infect Immun. 2009 Mar;77(3):1128-36. doi: 10.1128/IAI.01056-08. Epub 2008 Dec 29.

Supplemental Content

Loading ...
Support Center